Invention Grant
- Patent Title: Colorectal cancer recurrence gene expression signature
-
Application No.: US14907372Application Date: 2014-07-30
-
Publication No.: US11035006B2Publication Date: 2021-06-15
- Inventor: Michael Schell , Timothy Yeatman
- Applicant: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. , GIBBS CANCER CENTER
- Applicant Address: US FL Tampa; US SC Spartanburg
- Assignee: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.,GIBBS CANCER CENTER
- Current Assignee: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.,GIBBS CANCER CENTER
- Current Assignee Address: US FL Tampa; US SC Spartanburg
- Agency: Meunier Carlin & Curfman LLC
- International Application: PCT/US2014/048887 WO 20140730
- International Announcement: WO2015/017537 WO 20150205
- Main IPC: G01N33/48
- IPC: G01N33/48 ; C12Q1/6886 ; G06G7/58
Abstract:
Disclosed are gene signatures that may be used to predict the recurrence of colorectal cancer in a human patient. These signatures can be used to determine when to treat a patient with post-operative adjuvant chemotherapy, i.e., when a high risk of colorectal cancer recurrence is predicted.
Public/Granted literature
- US20160208333A1 COLORECTAL CANCER RECURRENCE GENE EXPRESSION SIGNATURE Public/Granted day:2016-07-21
Information query
